Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

Trump told reporters that he may give a lot of countries “breaks” from his reciprocal tariff move, without giving details.

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...